Brunner H R, Nussberger J, Bidiville J, Waeber G, Porchet M, Waeber B
Division of Nephrology and Hypertension, Centre Hospitalier Universitaire, Lausanne, Switzerland.
J Cardiovasc Pharmacol. 1987;10 Suppl 10:S87-9.
The acute blood pressure response to an angiotensin converting enzyme inhibitor (enalaprilat) was compared in patients with uncomplicated essential hypertension with that obtained under similar conditions with a calcium entry blocker (nifedipine). The patients were studied after a 3 week washout period. At a 48 h interval, each patient received in randomized order either enalaprilat (5 mg i.v.) or nifedipine (10 mg p.o.). Enalaprilat and nifedipine were equally effective in acutely lowering blood pressure. However, good responders to one agent were not necessarily good responders to the other.
在无并发症的原发性高血压患者中,比较了血管紧张素转换酶抑制剂(依那普利拉)与钙通道阻滞剂(硝苯地平)在相似条件下对急性血压反应的影响。在为期3周的洗脱期后对患者进行研究。每隔48小时,每位患者随机接受依那普利拉(静脉注射5毫克)或硝苯地平(口服10毫克)。依那普利拉和硝苯地平在急性降低血压方面同样有效。然而,对一种药物反应良好的患者对另一种药物不一定反应良好。